Johns Hopkins University

JHU Robotic System Remotely Controls Ventilators In COVID-19 Patient Rooms

Device could help save on PPE, restore more time for patient care
12-Aug-2020 1:10 PM EDT, by Johns Hopkins University

Newswise — A new robotic system allows medical staff to remotely operate ventilators and other bedside machines from outside intensive care rooms of patients suffering from infectious diseases.

The system, developed by a team of Johns Hopkins University and Medicine researchers, is still being tested, but initial trials have demonstrated how it could be deployed to help hospitals preserve protective gear, limit staff exposure to COVID-19 and provide more time for clinical work.

The invention’s rapid development since March is the result of a collaboration between robotics researchers from the Whiting School of Engineering and respiratory clinical staff from Johns Hopkins Medicine, working together to tackle one of the most vexing treatment issues to arise during the pandemic.

“When the crisis began to get very severe we started to think about what we could do to help,” said robotics professor Russell Taylor, who specializes in computer-integrated interventional medicine and supervised the effort. “One of the needs that came through very clearly was the challenge of providing care to patients on ventilators in intensive care units.”

Sajid H. Manzoor, director of adult respiratory therapy at Johns Hopkins Hospital, saw those challenges first-hand. “Two of the toughest challenges we faced at the peak of COVID-19 were staffing and PPE,” Manzoor said.

The need was identified early in the pandemic during brainstorming sessions with robotics researchers and medical staff from Johns Hopkins and the University of Maryland. Those in attendance identified several bottlenecks to delivering care that might benefit from robotic solutions, including testing patients, disinfecting and cleaning, and operating ICU ventilators.

The pandemic spurred a massive surge of highly infectious, intensive care patients requiring ventilators, infusion pumps and other support equipment. Treating them requires hospital personnel to change protective gear every time they enter rooms, even for minor adjustments to machines.

The process burns through limited supplies of personal protective equipment and wastes the precious time of medical staff. In addition, personnel are stretched thin because security procedures require that an additional person assist with the changing of gowns, gloves, masks and other gear.  

“This remote-control system will be a force multiplier for our frontline clinicians,” said Jonathan Cope, a respiratory therapist who assisted with the project. “Being able to save time to deliver more care to more patients will pay huge dividends when we face massive patient surges during pandemics.”  

The system could help hospitals handle all types of infectious diseases.

During one brainstorming session in March, researchers and clinicians from Hopkins and UM seized on the remote control idea floated by University of Maryland Shock Trauma Center’s Sarah Murthi.

UM student Misha Khrenov  working under mechanical engineering professor Axel Krieger, who joined Hopkins in July and Johns Hopkins LCSR research scientists Balázs P. Vágvölgyi built the working prototype.  

The robotic device is affixed to the ventilator’s touch screen with a horizontal bar secured across the top edge. The bar serves as a stationary track for the back-and-forth movement of two connected vertical bars that extend the full height of the screen. As the vertical bars sweep across the screen, a stylus they carry moves up and down according to its commands, similar to how an Etch A Sketch moves its drawing tool along an X-Y axis. A camera connected to the top bar sends an image of the screen to the operator’s tablet outside the room.

During a recent test at the Johns Hopkins Hospital Biocontainment Unit, Cope used the tablet to change oxygen percentage and volume delivered by a ventilator attached to a mannequin in an adjoining room.

“Whether it’s for Covid or the next pandemic, there is always going to be a need for this,” he said. “It will definitely end up in the ICU environment in the coming years.”

###

 

Johns Hopkins University news releases are available online, as is information for reporters. To arrange a video or audio interview with a Johns Hopkins expert, contact a media representative listed above or visit our studio web page. Find more Johns Hopkins stories on the Hub




Filters close

Showing results

1120 of 3699
Newswise: Hackensack Meridian School of Medicine Launches ‘Support Our Schools’ to Meet COVID-19 Challenges
Released: 19-Oct-2020 12:05 PM EDT
Hackensack Meridian School of Medicine Launches ‘Support Our Schools’ to Meet COVID-19 Challenges
Hackensack Meridian Health

The new COVID SOS (Support Our Schools) initiative aims to provide expertise about opening, and opening safely, to select school districts in underserved communities who had previously partnered with the Hackensack Meridian School of Medicine’s innovative Human Dimension program.

access_time Embargo lifts in 2 days
Embargo will expire: 20-Oct-2020 11:00 AM EDT Released to reporters: 19-Oct-2020 11:50 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Oct-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Oct-2020 11:10 AM EDT
New lab test clarifies the potential protective effects of COVID-19 antibodies
Ohio State University

Scientists have developed a new lab testing procedure for the detection of antibodies against SARS-CoV-2 that gives results more quickly than existing assays and specifically identifies so-called “neutralizing” antibodies.

Newswise: Mouthwashes, oral rinses may inactivate human coronaviruses
Released: 19-Oct-2020 10:55 AM EDT
Mouthwashes, oral rinses may inactivate human coronaviruses
Penn State College of Medicine

Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.

Released: 19-Oct-2020 10:50 AM EDT
Public health experts at DSHS and UTHealth collaborate on nation’s largest COVID-19 serological testing assessment
University of Texas Health Science Center at Houston

To help public health professionals and scientists better understand the spread of COVID-19 in Texas and the immune response it causes in individuals, researchers at The University of Texas Health Science Center at Houston (UTHealth) are partnering with the Texas Department of State Health Services (DSHS) to launch the Texas Coronavirus Antibody Response Survey (Texas CARES). Texas CARES will determine the proportion of people throughout Texas who have COVID-19 antibodies, indicating a past infection and presumably some degree of immune protection.

Newswise: Preclinical testing of inhaled monoclonal antibody for COVID-19 shows therapeutic efficacy
Released: 19-Oct-2020 10:25 AM EDT
Preclinical testing of inhaled monoclonal antibody for COVID-19 shows therapeutic efficacy
University of Alabama at Birmingham

An inhaled monoclonal antibody treatment against the SARS-CoV-2 virus may lead to self-administered therapy for COVID-19, according to preclinical tests. It was discovered at UAB and the Texas Biomedical Research Institute, and it has been licensed for development to Aridis Pharmaceuticals.

Newswise:Video Embedded musical-instruments-don-t-spread-aerosols-as-far-as-you-might-think
VIDEO
Released: 19-Oct-2020 8:55 AM EDT
Musical instruments don’t spread aerosols as far as you might think
University of Minnesota College of Science and Engineering

A new study by University of Minnesota College of Science and Engineering researchers has found that wind instruments typically do not spread aerosols farther than one foot. The researchers suggest that mitigation strategies including social distancing, putting masks over instruments, and using portable filters can help reduce the risk of spreading COVID-19 on musical stages.

Released: 19-Oct-2020 8:35 AM EDT
Texas Biomed with the University of Alabama at Birmingham and Aridis Pharmaceuticals develop a neutralizing human monoclonal antibody against SARS-CoV-2
Texas Biomedical Research Institute

Texas Biomedical Research Institute (Texas Biomed) Professor Luis Martinez-Sobrido, Ph.D., recently released study findings, alongside colleagues at the University of Alabama at Birmingham and Aridis Pharmaceuticals, Inc. indicating that a human monoclonal antibody (hmAb) 1212C2 showed promise for further clinical development for preventative use or as a therapy for SARS-CoV-2, the virus that causes COVID-19. Earlier this year, the consortium of scientists isolated specific B cells from patients infected with SARS-CoV-2 and developed a panel of hmAbs that not only bind to SARS-CoV-2 infected cells, but also neutralize the ability of the virus to infect cells. The hmAb 1212C2 was subsequently licensed to Aridis Pharmaceuticals.

Released: 16-Oct-2020 3:05 PM EDT
How to have a safe and fun Halloween during the COVID-19 pandemic
University of Chicago Medical Center

Dr. Poj Lysouvakon, pediatric director of the Mother-Baby Unit at the University of Chicago Medicine Comer Children’s Hospital, says it's still possible to have a safe and fun Halloween this year. Here's how.

Released: 16-Oct-2020 3:00 PM EDT
What San Diego's Hepatitis A outbreak can teach us during COVID-19
San Diego State University

In an age when many people get their news from social media, ensuring health information is communicated accurately and understood clearly is critical, especially during infectious disease outbreaks.


Showing results

1120 of 3699

close
1.11227